Medtronic plc (MDT): who owns it and who trades it
As of Nov 16, 2026, MDT insiders reported 18 open-market sales worth $14.7M and no purchases in the last 12 months, with 41% of the sale value made under pre-set 10b5-1 plans. The largest seller was Harry Skip Kiil (Vice president), with $5.6M. 9 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Medtronic
From the latest filingsOverall: more selling than buying. Insiders and Congress mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns MDT
2,121 funds and institutions reported MDT shares worth $87.7B at the end of Q2 2026, about 86% of the company. The largest holder is BlackRock, Inc. with 8.9%.
Funds and institutions (13F) 86%Everyone else 14%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 114.02M | 8.91% | $8.9B | +1% |
| Vanguard Capital Management LLC | 83.82M | 6.55% | $6.6B | +1% |
| State Street Corp | 63.40M | 4.95% | $5B | +3% |
| Vanguard Portfolio Management LLC | 34.06M | 2.66% | $2.7B | +2% |
| Geode Capital Management, LLC | 30.19M | 2.36% | $2.4B | +5% |
| JPMorgan Chase & Co | 27.78M | 2.17% | $2.2B | – |
| First Eagle Investment Management, LLC | 27.57M | 2.15% | $2.2B | +174% |
| Bank of America Corp | 21.32M | 1.67% | $1.7B | -18% |
| Massachusetts Financial Services Co | 19.87M | 1.55% | $2.6B | -7% |
| Morgan Stanley | 19.44M | 1.52% | $1.5B | -6% |
| Deutsche Bank Ag\ | 18.45M | 1.44% | $1.4B | -3% |
| Invesco Ltd. | 17.89M | 1.40% | $1.4B | +7% |
| Franklin Resources Inc | 17.55M | 1.37% | $1.4B | +24% |
| Norges Bank | 16.55M | 1.29% | $1.3B | – |
| Royal Bank of Canada | 16.03M | 1.25% | $1.3B | +13% |
| Bank of New York Mellon Corp | 14.69M | 1.15% | $1.1B | -5% |
| Capital Research Global Investors | 13.26M | 1.04% | $1B | -68% |
| Arrowstreet Capital, Limited Partnership | 12.89M | 1.01% | $1B | +177% |
| Northern Trust Corp | 11.63M | 0.91% | $910M | -3% |
| Ameriprise Financial Inc | 11.57M | 0.90% | $905M | -3% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, MDT insiders reported $0 of open-market purchases and $14.7M of sales. 41% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Michael Marinaro | Vice president | Sale plan | 10,420 | $96.00 | $1M | Form 4 |
| Oct 15, 2026 | Geoffrey Martha | CEO | Sale plan | 50,000 | $95.00 | $4.8M | Form 4 |
| Sep 16, 2026 | Harry Skip Kiil | Vice president | Sale | 1,483 | $93.65 | $139K | Form 4 |
| Jul 8, 2026 | Matthew R. Walter | Vice president | Sale plan | 3,102 | $83.15 | $258K | Form 4 |
| Jun 8, 2026 | Harry Skip Kiil | Vice president | Sale | 228 | $80.45 | $18.3K | Form 4 |
| Jun 8, 2026 | Harry Skip Kiil | Vice president | Sale | 3,961 | $80.44 | $319K | Form 4 |
| Feb 19, 2026 | Harry Skip Kiil | Vice president | Sale | 30,568 | $97.66 | $3M | Form 4 |
| Feb 19, 2026 | Harry Skip Kiil | Vice president | Sale | 19,255 | $97.77 | $1.9M | Form 4 |
| Feb 19, 2026 | Harry Skip Kiil | Vice president | Sale | 385 | $97.82 | $37.7K | Form 4 |
| Feb 19, 2026 | Harry Skip Kiil | Vice president | Sale | 1,648 | $97.86 | $161K | Form 4 |
| Feb 19, 2026 | Harry Skip Kiil | Vice president | Sale | 668 | $97.83 | $65.4K | Form 4 |
| Nov 19, 2025 | Gregory L Smith | Vice president | Sale | 500 | $102.08 | $51K | Form 4 |
| Nov 19, 2025 | Gregory L Smith | Vice president | Sale | 325 | $102.06 | $33.2K | Form 4 |
| Nov 19, 2025 | Gregory L Smith | Vice president | Sale | 227 | $102.05 | $23.2K | Form 4 |
| Nov 19, 2025 | Gregory L Smith | Vice president | Sale | 825 | $102.04 | $84.2K | Form 4 |
| Nov 19, 2025 | Gregory L Smith | Vice president | Sale | 1,995 | $102.03 | $204K | Form 4 |
| Nov 19, 2025 | Gregory L Smith | Vice president | Sale | 1,942 | $101.99 | $198K | Form 4 |
| Nov 19, 2025 | Gregory L Smith | Vice president | Sale | 24,186 | $101.93 | $2.5M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Harry Skip Kiil | EVP & President Cardiovascular | – | $5.6M | Sep 16, 2026 |
| Geoffrey Martha | Chairman and CEO, Director | – | $4.8M | Oct 15, 2026 |
| Gregory L Smith | EVP Global Ops & Supply Chain | – | $3.1M | Nov 19, 2025 |
| Michael Marinaro | EVP, Pres MedSurg and Americas | – | $1M | Oct 15, 2026 |
| Matthew R. Walter | SVP, Chief HR Officer | – | $258K | Jul 8, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MDT short interest
Low short interest. 1.8% of MDT shares are sold short: about 1 share in 56. Over the last 12 reports the number of shares short went up 57%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 22.95M MDT shares were sold short, 1.8% of the shares outstanding, down 83.5% from the report before. At the average daily volume of 12.37M shares, buying them all back would take about 1.9 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 22.95M | 1.79% | -83% | 12.37M | 1.9 |
| Oct 15, 2026 | 139.00M | 10.87% | +248% | 47.50M | 2.9 |
| Sep 30, 2026 | 39.97M | 3.13% | +132% | 14.67M | 2.7 |
| Sep 15, 2026 | 17.23M | 1.35% | +42% | 8.73M | 2.0 |
| Aug 31, 2026 | 12.13M | 0.95% | -15% | 7.26M | 1.7 |
| Aug 14, 2026 | 14.35M | 1.12% | -21% | 6.38M | 2.2 |
| Jul 31, 2026 | 18.12M | 1.42% | -5% | 7.64M | 2.4 |
| Jul 15, 2026 | 19.03M | 1.49% | -0% | 7.78M | 2.5 |
| Jun 30, 2026 | 19.09M | 1.49% | +4% | 11.02M | 1.7 |
| Jun 15, 2026 | 18.43M | 1.44% | +10% | 12.16M | 1.5 |
| May 29, 2026 | 16.76M | 1.31% | +14% | 11.26M | 1.5 |
| May 15, 2026 | 14.65M | 1.14% | +0% | 9.88M | 1.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded MDT
Since Nov 17, 2024, 10 members of Congress reported 5 purchases and 13 sales of MDT. The latest was a sale by Kevin Hern on Aug 24, 2026, reported Sep 1, 2026.
Purchases 5Sales 13
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Kevin Hern (R-OK) | Sale | $15K–$50K | Joint | Sep 1, 2026 | Report |
| Jul 30, 2026 | Richard McCormick (GA) | Sale | $1K–$15K | Self | Aug 14, 2026 | Report |
| May 15, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Jun 8, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Mar 20, 2026 | Kevin Hern (R-OK) | Sale | $15K–$50K | Joint | Apr 3, 2026 | Report |
| Dec 18, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | Jan 15, 2026 | Report |
| Nov 13, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Dec 11, 2025 | Report |
| Nov 5, 2025 | Richard McCormick (GA) | Purchase | $1K–$15K | Self | Dec 9, 2025 | Report |
| Aug 14, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Sep 11, 2025 | Report |
| May 15, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $1K–$15K | Self | May 31, 2025 | Report |
| May 8, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | Jun 22, 2025 | Report |
| May 7, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Aug 5, 2026 | Report |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Self | Apr 28, 2025 | Report |
| Mar 24, 2025 | George Whitesides (D-CA) | Sale | $50K–$100K | Self | Apr 23, 2025 | Report |
| Mar 20, 2025 | Bruce Westerman (R-AR) | Sale | $1K–$15K | Self | Apr 16, 2025 | Report |
| Mar 4, 2025 | Bruce Westerman (R-AR) | Purchase | $1K–$15K | Self | Apr 16, 2025 | Report |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $1K–$15K | Self | Mar 27, 2025 | Report |
| Jan 6, 2025 | Emily Randall (D-WA) | Sale | $1K–$15K | Spouse | Feb 11, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Medtronic company events
Medtronic filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 19, 2026.
- Oct 19, 2026LeadershipThe Board of Directors of Medtronic plc approved the appointment of Michael Marinaro, Executive Vice President and President, Medical Surgical Portfolio, Americas, and Global Commercial Operations to the role of President, Medtronic, effective October 14, 2026. Filing
- Sep 17, 2026AnnouncementMedtronic plc, a public limited company organized under the laws of Ireland, commenced an offer to exchange up to 225,361,295 newly issued shares of common stock, par value $0.01 per share, of MiniMed Group, Inc., a Delaware corporation, for outstanding ordinary shares of Medtronic, par value… Filing
- Sep 1, 2026ResultsReleased financial results. Filing
- Jun 3, 2026ResultsReleased financial results. Filing
- May 18, 2026LeadershipMedtronic plc announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President… Filing
- Apr 27, 2026AnnouncementShared information with investors. Filing
- Mar 24, 2026AnnouncementShared information with investors. Filing
- Feb 17, 2026ResultsReleased financial results. Filing
- Nov 18, 2025ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
How Medtronic makes money
Cardiovascular brought in 38% of Medtronic's revenue ($14B of $36.4B) in fiscal 2025. Neuroscience Group was next, at 28%.
By business segment, fiscal 2025
From Medtronic's annual report (10-K) for the year ended Apr 24, 2026, filed Jun 18, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money
Medtronic financials
Famous investors that hold MDT
9 of the 50 well-known investors we track reported holding MDT in their latest 13F filing. The largest position is Israel Englander's, worth $671M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 7.77M | $671M | 0.5% | +746% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 3.77M | $326M | 0.2% | -30% |
| Richard Pzena · Pzena Investment Management | Q3 2026 | 3.08M | $266M | 0.8% | -2% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 2.73M | $236M | 0.4% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 887,841 | $76.6M | 0.1% | -72% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 488,043 | $42.1M | 0.2% | +1% |
| Jeremy Grantham · GMO | Q3 2026 | 162,454 | $14M | 0.0% | +128% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 113,168 | $9.8M | 0.0% | -3% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 13,323 | $1.1M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named MDT in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 10, 2026 | STATE STREET CORPORATION | 13G | 5.2% |
| Nov 10, 2026 | STATE STREET CORPORATION | 13G | 5.2% |
Questions about Medtronic plc (MDT) stock
Who owns the most MDT stock?
The largest reported owner of Medtronic plc (MDT) is BlackRock, Inc., with 8.9% of the company. In total, 2,121 funds and institutions reported holding MDT at the end of Q2 2026, together about 86% of the shares. See the largest owners.
Are MDT insiders buying or selling?
In the last 12 months, MDT insiders reported no open-market purchases and 18 sales worth $14.7M. The latest trade was on Oct 15, 2026. See every trade.
What is the short interest in MDT?
As of Oct 30, 2026, 22.95M MDT shares were sold short, 1.8% of the shares outstanding, down 83.5% from the report before. At the average daily volume of 12.37M shares, buying them all back would take about 1.9 trading days (days to cover). See the history.
Have members of Congress traded MDT?
Yes. 10 members of Congress reported 5 purchases and 13 sales of MDT since Nov 17, 2024. The latest was reported on Sep 1, 2026. See the trades.
How does Medtronic make money?
Cardiovascular brought in 38% of Medtronic's revenue ($14B of $36.4B) in fiscal 2025. Neuroscience Group was next, at 28%. See the full split.
Which famous investors hold MDT?
9 of the 50 well-known investors we track reported MDT in their latest 13F filing, including Israel Englander, Ken Griffin, Richard Pzena. The largest position is worth $671M. See all holders.
Executive pay
Medtronic's chief executive was paid a total of $22.9M for the year ended Apr 24, 2026, up 8% from $21.2M the year before. In the last 12 months, Medtronic's executives and directors bought no stock on the open market and sold $14.7M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.